Bernard Birkett - 18 Feb 2025 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Reporting relationship: Sr VP, Chief Financial Officer
Issuer ticker: WST
Reported as of: 18 Feb 2025
Net transaction value: +$133,133
SEC form: 4
Accepted by SEC: 20 Feb 2025, 21:44:56 UTC
Prior SEC filing: 22 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Louis Lalli, as an agent for Bernard Birkett

Key filing fact

Bernard Birkett filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 20 Feb 2025.

Key facts

This page summarizes Bernard Birkett's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 20 Feb 2025, 21:44.

Change

Previous filing in this sequence was filed on 22 Feb 2024.
Current net transaction value: +$133,133.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WST transaction

Common Stock

Options Exercise

Transaction value: $164,443
Shares: +779
Change %: +11%
Price: $211.00
Shares after: 7,669
Date: 18 Feb 2025
Ownership: Direct

WST transaction

Common Stock

Tax liability

Transaction value: $50,168
Shares: -238
Change %: -3.1%
Price: $211.00
Shares after: 7,431
Date: 18 Feb 2025
Ownership: Direct

WST transaction

Common Stock

Options Exercise

Transaction value: $26,370
Shares: +125
Change %: +1.7%
Price: $211.00
Shares after: 7,556
Date: 18 Feb 2025
Ownership: Direct

WST transaction

Common Stock

Tax liability

Transaction value: $7,513
Shares: -36
Change %: -0.47%
Price: $211.00
Shares after: 7,520
Date: 18 Feb 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WST transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +4,020
Change %
Price: $0.000000
Shares after: 4,020
Date: 18 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,020
Exercise price: $211.00
Footnotes: F1

WST transaction Derivative

Rst. Stock Unit

Award

Transaction value: $0
Shares: +1,740
Change %
Price: $0.000000
Shares after: 1,740
Date: 18 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,740
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This award vests in four equal installments beginning on February 18, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .